What therapeutic areas does AILEX PHARMS LLC focus on?

AILEX PHARMS LLC focuses primarily on Cardiovascular.

Data updated: Mar 10, 2026

AILEX PHARMS LLC

Q: What drugs does AILEX PHARMS LLC make?

AILEX PHARMS LLC has 3 FDA-approved drugs including BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE, SODIUM PHENYLACETATE AND SODIUM BENZOATE.

Cardiovascular

Generics

AILEX PHARMS LLC is a generic drug manufacturer focused on Cardiovascular. Key products include SODIUM PHENYLACETATE AND SODIUM BENZOATE.

2016

Since

Drugs

Trials

Approved (2yr)

Key Drugs

BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE

bismuth subsalicylate

7 indications · 2018

SODIUM PHENYLACETATE AND SODIUM BENZOATE

sodium benzoate

3 indications · 2016

Recent Activity

CROMOLYN SODIUM 2025-10-02

Manufacturing (CMC)

BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE 2025-03-31

Labeling

BISMUTH SUBSALICYLATE, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE 2024-07-08

Labeling

SEC Filings ProEarly access

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 100%

1 drugs

Pipeline Strength ProEarly access

Competitors ProEarly access

Johnson & Johnson big-pharma

Cardiovascular

Bayer big-pharma

Cardiovascular

AILEX PHARMS LLC

Key Drugs

Recent Activity

Therapeutic Focus

Pipeline Strength ProEarly access

Competitors ProEarly access

All Drugs (3)

Active (3)

Discontinued (0)

Company Info